Obstetric Emergencies in India: Overview
Obstetric Emergencies in India: Overview
Pregnancy is an undoubtedly magical period in a woman's life with its unique set of joys and
challenges. There is something quite remarkable about the process, the excitement mingling
with fear, delight with discomfort, preparedness with the feeling that nothing you do is just
quite enough.
As peaceful as she may want it to be, it can be a stressful time too, filled with trepidation for
the baby's health and her own.
Every pregnant woman faces the risk of unforeseeable complications that can harm her or her
unborn baby. These women represent a vulnerable section of our population, where early
childbearing age, poor nutrition, and limited access to healthcare, education, and sanitation
pose threats to pregnant women.
Therefore, the healthcare system needs to be geared to combat complications and effectively
prepare the mother for birth and requires widespread community support to do so. It becomes
increasingly vital to characterize the spectrum of pregnancy-related emergencies to minimize
maternal and infant mortality.
Pregnant women presenting to the Emergency Department (ED) require thorough evaluation
for early identification of life-threatening complications.
Common obstetric issues seen in ED are hyperemesis gravidarum, abortions,
eclampsia/preeclampsia, etc.
Non-obstetric causes include urinary tract infections including pyelonephritis, lower
respiratory tract infections, acute undifferentiated febrile illnesses, deep venous thrombosis,
etc.
The majority of the emergencies in these women have been found to be symptoms suggestive
of a miscarriage, some of which can be prevented if early and efficient treatment is instituted.
Improved access to preventive care in India, particularly in rural areas, could be beneficial to
countering high rates of maternal and child morbidity.(1)
Obstetric emergencies
Obstetric emergencies refer to clinical conditions that require immediate interventions to
prevent mortality or morbidity to a mother and or her baby.
Easy access to an appropriate healthcare facility, problem recognition and provision of the
best possible standard of care is the sine qua non to 'successful' management.
The bane of success is usually lack of and or delay in one or more of the following:
Information provision,
Primary Prevention (where applicable),
Resuscitation,
Access to a healthcare facility,
Diagnosis and Treatment.
The management of emergencies is usually the responsibility of hospital obstetricians. As
more maternity care is now given in the community, however, midwives, general
practitioners, and paramedics may be involved and must know the outlines of the
management of emergencies and the possible side effects.
If such a situation occurs outside the hospital, arrangements must be made to safely and
promptly transport the woman to the obstetric unit safely and promptly. All emergency
protocols should have been considered beforehand and mutually agreed upon by
obstetricians, midwives, general practitioners, and paramedics.
Everybody then knows their immediate priority, and hazards to the woman can be minimized.
The first principles of dealing with obstetric emergencies are the same as for any emergency
(see to the airway, breathing, and circulation), but remember that in obstetrics there are two
patients; the fetus is very vulnerable to maternal hypoxia.
Types-
In the virtual issue of Case Reports in Women's Health, reflective cases on obstetric
emergencies are highlighted. These include
1. Retinal detachment without hypertension,
2. Pulmonary oedema from ritodrine use,
3. Pre-eclampsia with severe features (HELLP syndrome, sub-capsular hematoma) and
one of its precursors (mirror syndrome) and an imitator (fatty liver disease).
4. Ectopic pregnancies,
5. Advanced extra-uterine pregnancy,
6. Placenta accreta spectrum disorders,
7. Intra-placental choriocarcinoma,
8. Uterine dehiscence/rupture,
9. Premature rupture of membranes,
10. Acute abdominal pain,
11. Obstetric haemorrhages,
12. Delayed-interval delivery in monochorionic diamniotic twin and
13. Infections such as pyoderma gangrenosum.(3)
Abruption of placenta
Definition-
An abruption is a death threat to the fetus and a hazard to the mother. When the placenta
separates from its bed (probably because of the rupture of a malformed blood vessel), the
damage to the fetus follows not just because of the barrier that the clot makes between the
placental bed and villi but also because the release of prostaglandins causes a major degree of
uterine spasm.
Clinical features-
This interferes with the perfusion of the placenta, which remains attached. Blood tracking
into the myometrium often goes as far as the peritoneum over the uterus, causing much pain
and shock, with spasms of the uterine muscle. In major degrees of placental abruption, the
woman is shocked well beyond the apparent amount of blood loss and needs urgent transport
into the hospital.
Usually, the placenta is implanted on the anterior wall of the uterus, but sometimes it is
posterior when the abruption is less painful and not so severe that the mother is shocked; the
fetus may still be at risk, however.
o Most women with a severe abruption that kills the fetus will go into spontaneous labor
soon and have an easy delivery, but cesarean section is occasionally necessary for
maternal indications alone.
Placenta previa
The blastocyst occasionally implants in the lower part of the uterus. Stretching and thinning
of the uterine muscle of the lower segment in the third trimester may sheer off part of the
placental attachment. This is accompanied by painless bleeding.
Often the fetus is not affected by the first small bleeds, but they should be taken seriously for
there is a risk that the mother could have a much larger bleed.
Hence, women with bright red, painless vaginal bleeding are considered to have placenta
praevia until proven otherwise and should be admitted to hospital.
Vaginal ultrasound examination is the best technique for investigating possible placenta
praevia, but, although it has a high sensitivity and specificity for central placenta praevia in
the third trimester, it is much less precise in the late second trimester or for marginal placenta
praevia.
Management should therefore always be based on appropriate clinical judgment.
If placenta praevia is confirmed the woman should stay in hospital for at least 48 hours after
the bleeding has stopped. Management is conservative, even to the level of giving blood
transfusions for severe bleeds until the fetus is mature (at about 36 weeks).
Studies do not show any benefit in keeping women in hospital until delivery, provided that
they have a telephone at home and live close enough to the hospital to be brought in by the
emergency services within 20 minutes if they start bleeding again.
Unless it is very obvious—for example, a complete placenta praevia on ultrasound
examination, together with a transverse lie of the fetus—placenta praevia is sometimes
confirmed by examination under general anaesthesia in the at, proceeding in most instances
to caesarean section performed by a senior obstetrician.
Occasionally, if the placenta is anterior and only just engaging in the lower segment, the
membranes may be ruptured and a vaginal delivery expected, as the head coming down into
the mother's pelvis will compress the bleeding placental bed against the back of the pubis
symphysis.
The same cannot be said for any degree of posterior placenta praevia. After delivery, a
postpartum hemorrhage is likely because the placental bed is situated over less well-
contracting uterine muscle and may be well bleed despite oxytocic stimulation. This often
requires a blood transfusion.(4)
Postpartum haemorrhage
After a normal delivery a woman commonly loses up to 300ml of blood. As her blood
volume has increased because of fluid retention during pregnancy, this is a loss which can be
coped with readily.
However, a loss of >500ml measured clinically in the first 24 hours is considered to be a
primary postpartum haemorrhage.
Blood loss is commonly underestimated by the attending practitioners. The mother should be
watched carefully and treatments given to prevent any further loss. If the uterus has not
contracted firmly, manual stimulation may work by rubbing up a contraction, and a further
oxytocic is given.
If the placenta is incomplete the uterine cavity is explored for the remaining lobules whose
presence in the uterine cavity may prevent the organ contracting down. If neither of these
conditions exists, trauma to the lower uterus, cervix, or upper vagina may be the cause of the
bleeding.
Such traumas should be looked for (in theatre with a good light) and sutured appropriately. A
rare cause of continuing primary postpartum haemorrhage is a rupture of the uterus.
This needs diagnosis and treatment with either hysterectomy or abdominal re-suturing.
After the first 24 hours, any bleeding is a secondary postpartum haemorrhage. It is
commonly associated with infection, which should be treated vigorously with intravenous
antibiotics. If it persists, suction evacuation of the uterus should be undertaken by a senior
obstetrician; perforation of the soft uterus is a major risk in this situation.
A complication of severe and prolonged blood loss is a consumptive coagulopathy, when
the mother's blood does not clot owing to interference with the clotting cascade. The
continuing cooperation of a senior haematologist is essential. The mother continues to bleed
not just from the placental bed but from other sites in the body. This needs firm and prompt
correction so that full coagulation can be restored. Giving cryoprecipitate (frozen precipitate)
provides the missing components.(4)
Infection
After delivery, the genital tract has several sites of potential ingress of bacteria. The placental
bed itself is a large raw area, and ascending infection from the lower genital tract may be
assisted by previous intrauterine procedures—for example, forceps delivery.
Infection of the cervix or, uncommonly, of the episiotomy site, may also occur; the breast can
also be a site of infection in the puerperium.(4)
Umbilical cord prolapse
(Simulation)
Umbilical cord prolapse is when the umbilical cord exits the cervical os before the fetal
presenting part.
Compression of the cord results in vasoconstriction and resultant fetal hypoxia, which can
lead to fetal death or disability if not rapidly diagnosed and managed.
Objectives:
Describe the clinical presentation of umbilical cord prolapse.
Outline the key steps in the acute management of umbilical cord prolapse.
Review alternative management strategies that can be utilized after initial attempts at
funic decompression have failed or in cases where obstetric care is not immediately
available.
Explain strategies to improve care coordination between the interprofessional teams
caring for patients with umbilical cord prolapse to improve outcomes.
Aetiology
Certain features of pregnancy increase the risk for the development of umbilical cord
prolapse by preventing appropriate engagement of the presenting part with the
pelvis. These include
fetal malpresentation,
multiple gestations,
polyhydramnios,
preterm rupture of membranes,
intrauterine growth restriction,
preterm delivery, and
fetal and cord abnormalities.
Nearly half of the cases of umbilical cord prolapse can be attributable to iatrogenic
causes.
Iatrogenic risk factors include
amniotomy without an engaged fetal presenting part
attempted external cephalic version in the setting of ruptured membranes,
amnioinfusion,
placement of a fetal scalp electrode or intrauterine pressure catheter, or
the use of a cervical ripening balloon.
Epidemiology
Estimates of the incidence of umbilical cord prolapse range from 1.4 to 6.2 per 1000. The
majority of cases of umbilical cord prolapse occur in single-gestation pregnancies; in twin
gestations, the incidence increases in the second twin.
Most prolapses occur shortly after rupture of membranes; one study estimates that 57%
occur within five minutes of membrane rupture while 67% occur within one hour of rupture.
The incidence of umbilical cord prolapse is on a downward trend, which is thought to be
secondary to the widespread use of cesarean sections for many of the risk factors of cord
prolapse, such as fetal malpresentation.
It is associated with high perinatal mortality, ranging from 23% to 27% in low-income
countries to 6% to 10% in high-income countries.(5)
Decreasing rates of grand multiparity worldwide are also thought to contribute to the reduced
incidence.
In all presented cases the umbilical cord prolapse was diagnosed based on the
sudden changes in the CTG traces. However, all patients had risk factors for this
pathology which were spotted during the initial clinical and anamnestic
assessment.
Healthcare practitioners from the labor ward department should also distinguish
between other causes of abnormal CTG traces and prepare for immediate action.
An acute hypoxia pattern (prolonged deceleration or bradycardia) should expedite
the delivery in irreversible cases such as uterine rupture and abruption and
immediate treatment or intrauterine resuscitation is needed in hypertonia or
epidural-induced maternal hypotension. In all other cases, the 3–6–9–12–15 min
rule should be applied
In the acute hypoxia pattern, the umbilical artery pH drops by 0.1 every 10 min. In
this situation, the 3–6–9–12–15-min rule must be applied (intrauterine
resuscitation by 6 min, move the patient to a suitable delivery location by 9 min, if
CTG trace is persistently bradycardic, commence delivery procedures by 12 min
and deliver the baby by 15 min), but only after acute accidents have been
excluded. (6)
Management
The definitive management of umbilical cord prolapse is expedient delivery; this is usually
by cesarean section. In rare cases, vaginal delivery or operative vaginal delivery may be
faster and, thus, preferable, but this should only occur under the presence and guidance of
an experienced obstetrician.
Until delivery is possible, the cornerstone of management of umbilical cord prolapse is
funic decompression, relieving the pressure on the cord by elevation of the fetal presenting
part. Studies suggest that the interval to funic decompression may be more important to
outcomes than interval to delivery.
Decompression should be done manually by the medical provider through the placement
of their finger or hand in the vaginal vault and gentle elevation of the presenting part off
the umbilical cord. The provider should be conscientious not to place any additional
pressure on the cord, as this can cause vasospasm and worsen outcomes.
Placement of the mother in a steep Trendelenburg or knee-chest position can also aid in
cord decompression. In cases of a potentially prolonged interval to delivery (i.e., the need
for transfer to a hospital with obstetric capabilities), saline infusion into the bladder may
aid in funic decompression and remove the need for continuous manual elevation by the
provider.
If fetal decelerations persist and delivery is not imminent, the administration of a tocolytic
can be attempted to relieve pressure on the umbilical vessels and to improve placental
perfusion, thereby improving blood flow to the fetus.
Reduction of the cord into the os, which was common before the widespread availability of
cesarean sections, has been associated with increased fetal mortality and is not routinely
recommended except in cases of an expected long interval to delivery where other
maneuvers have failed.
If the cord is visibly protruding from the introitus, it should remain warm and moist because
the ambient temperature is significantly colder than the temperature in the uterus and can
result in vasospasm of the umbilical arteries, contributing to fetal hypoxia. One method
described as preventing this is the replacement of the cord into the vaginal vault followed by
the insertion of a moist tampon to keep it in place.
In very rare cases of umbilical cord prolapse in peri-viable pregnancies, case studies
demonstrate that conservative management may allow the continuation of the pregnancy
until reaching a more desirable gestational age. However, a frank discussion should take
place with the patient regarding the experimental nature of this treatment and its potential
risks.
Pre-viable gestational age, lethal fetal abnormalities, or fetal demise are not indications for
expedient delivery, and instead, a dilation and evacuation or labor induction should be the
therapeutic choice, dependent on gestational age or maternal preference.
Vasa previa
Vasa previa occurs when fetal blood vessels that are unprotected by the umbilical cord or
placenta run through the amniotic membranes and traverse the cervix. Two types of vasa
previa have been described. Type I occurs when a velamentous cord is inserted between the
umbilical cord and placenta, and fetal vessels that run freely within the amniotic membranes
overlie the cervix or are near it. Pregnancies with resolved placenta previa or low-lying
placenta are at risk for type I vasa previa. Type II occurs when the placenta contains a
succenturiate lobe or is multilobed (typically bilobed), and fetal vessels that connect the 2
placental lobes course over or near the cervix. Although there are no standardized criteria
for how close the fetal vessels must be to the internal os to constitute vasa previa, a
threshold of 2 cm has been proposed. In 1 series, all emergent deliveries with vasa previa
had a fetal vessel within 2 cm of the cervical os.
Shoulder dystocia is an obstetric emergency that can complicate vaginal delivery and is
characterized by the failure to deliver the fetal shoulders solely using gentle downward
traction following expulsion of the head.
Shoulder dystocia results from the anterior fetal shoulder becoming impacted behind the
maternal pubic symphysis, or less commonly, the posterior fetal shoulder becoming lodged
behind the maternal sacral promontory.
Most shoulder dystocias are unpredictable and unavoidable; therefore, any clinician involved
with a vaginal delivery must have the clinical knowledge to promptly identify shoulder
dystocia and be prepared to perform any additional obstetric maneuvers required to effect
delivery.
When this vaginal delivery complication arises, competency in the recommended sequence
of maneuvers and coordinated management with interprofessional clinicians can prevent
permanent neonatal injury and asphyxiation.
However, clinicians deficient in this clinical knowledge may become a mechanism of greater
maternal and neonatal injury by attempting to resolve shoulder dystocia inappropriately.
Objectives:
Identify the relevant anatomy, physiology, and risk factors of shoulder dystocia.
Effectively implement the proper sequence of obstetric maneuvers recommended in
managing a shoulder dystocia.
Employ appropriate evaluation and management strategies for patients with shoulder
dystocia injuries.
Delineate how to effectively collaborate and communicate among the
interprofessional team when shoulder dystocia occurs to optimize outcomes for the
parturient and infant.
Etiology
The underlying cause of shoulder dystocia is the persistent anterior-posterior position of the
fetal shoulders as they enter the pelvic inlet or descent of the fetal shoulders simultaneously.
According to the American College of Obstetricians and Gynecologists (ACOG), the
following are the 3 primary mechanisms of this:
Increased resistance between the vaginal walls and the fetus (eg, fetal macrosomia)
A large fetal chest relative to the fetal head (eg, neonates of diabetic women)
Rapid descent prevents rotation of the bisacromal diameter within the pelvis (eg, a
precipitous delivery)
Risk factors
Maternal diabetes causes elevated glucose levels in the fetus, which stimulates it to produce
excess insulin, insulin-like growth factors, and growth hormone, potentially leading to large
for gestational age infants or infants with larger shoulders and increased abdominal-to-head
circumference ratios.
Larger infants may have difficulty traversing the fixed diameters of the maternal pelvis.
Despite this, the majority of shoulder dystocias still occur in nondiabetic mothers with
average-size infants, while many patients with diabetes or macrosomic infants do not have
shoulder dystocias.
For patients with a history of shoulder dystocia, operative (ie, forceps or vacuum) vaginal
delivery, or an infant with a brachial plexus injury in a prior pregnancy, the risk of recurrence
is estimated to be ≥10%.
For this reason, primary elective cesarean delivery may be considered after careful
evaluation of the entire clinical picture. For patients who elect to proceed with a trial of
labor, the delivering team must maintain heightened awareness and prepare for recurrent
shoulder dystocia.
Additional risk factors for shoulder dystocia include prior operative (ie, forceps or vacuum)
vaginal delivery, delivery of a large birthweight infant, increased maternal weight gain,
maternal obesity, and intrauterine fetal death. These factors, however, are often present
concurrently with other more significant risk factors (eg, fetal macrosomia and maternal
diabetes), making it difficult to isolate the individual risk associated with each clinical
feature.
Intrapartum conditions that may signal the possibility of impending shoulder dystocia include
a prolonged second stage of labor, failure of the fetal head to descend, and need for the
operative (ie, forceps or vacuum) vaginal delivery of the fetal head.
However, while it is essential to remain mindful of the risk factors for shoulder dystocia to
prepare for delivery properly, attempts to predict shoulder dystocia based on risk factors have
shown poor reliability and have a poor predictive value.
Epidemiology
Pathophysiology
Familiarity with the bony female pelvis is essential in understanding how shoulder dystocia
develops and provides insight into why the correct application of various maneuvers can
relieve shoulder dystocia.
The pelvic girdle is comprised of 4 bones and 3 joints. The bones consist of the sacrum, the
coccyx, and the two innominate bones formed by the fusion of the ilium, ischium, and pubic
rami. The joints include the sacroiliac joints bilaterally located between the sacrum and each
ilium, and the pubic symphysis joint, where the right and left pubic rami meet anteriorly.
The space enclosed by the pelvic girdle has a bowl-like shape and is divided into the greater
and the lesser pelvis. The greater pelvis (ie, false pelvis) refers to the superior portion
between the iliac wings. The lesser pelvis (ie, true pelvis) lies inferior to the greater pelvis
and is located between the sacrum and coccyx posteriorly and the pubic and ischial bones
anteriorly and laterally.
A somewhat round, bony ridge known as the pelvic brim is at the boundary between the
greater and lesser pelvis; it is comprised of the sacral promontory, the arcuate line on the
ilium, and the superior border of the pubic rami. The pelvic brim circumscribes an opening
known as the pelvic inlet. The pelvic inlet is thus the "entrance" into the lesser, or true,
pelvis. The pelvic outlet is the opening at the lower margin of the lesser pelvis. This margin
is made up posteriorly of the coccyx, posterolaterally of the sacrotuberous ligaments, laterally
of the ischial tuberosities, and anteriorly of the pubic arch. Thus, during labor and delivery,
the fetus must descend through the pelvic inlet, traverse the lesser pelvis, and emerge through
the pelvic outlet. Shoulder dystocia occurs when one of the fetal shoulders gets stuck behind
the pelvic brim.
Fetal Rotation Through the Lesser Pelvis
The obstetric (ie, true) conjugate is the distance between the sacral promontory and the
widest portion of the pubic symphysis, located between the superior and inferior margins of
the symphysis. The obstetric conjugate represents the smallest fixed distance through the
pelvic inlet. The obstetric conjugate in the average gynaecoid pelvis is approximately 11.5 to
12 cm, while the average transverse diameter is typically slightly larger at 13 cm. The largest
diameters of the fetal head are in the A-P plane, while the largest diameter of the fetal
shoulders is in the transverse plane. For the largest diameters of the fetal head and shoulders
to pass through the larger transverse diameter of the maternal pelvis, the fetus must rotate
through the true pelvis.
The fetal head typically passes through the pelvic inlet in a transverse position (ie, facing one
of the maternal sides). The fetus then internally rotates, more directly aligning its head and
shoulders in an A-P orientation (ie, facing either the maternal abdomen or back), which
allows its bisacromial diameter to align with the transverse diameter of the maternal pelvis.
The fetal head then extends with delivery and restitutes, realigning the fetal head, shoulders,
and rest of the body, which represents an external rotation. In some cases, especially with
larger infants, the fetal shoulders get stuck behind the bones of the pelvic inlet while
attempting to rotate, resulting in shoulder dystocia.
After delivery of the fetal head, the fetal trunk, including the chest, abdomen, and umbilical
cord, becomes compressed within the vaginal canal resulting in decreased fetal oxygenation
due to reduced blood flow through the umbilical cord. Additionally, the compression prevents
the fetus from expanding its lungs effectively until the body is fully delivered. Consequently,
rapid relief of shoulder dystocia to avoid fetal asphyxiation is critical in reducing infant
morbidity and mortality.
History and PE
During labor and delivery, it is always prudent for the delivering clinician to monitor the
position of the fetus and its overall progress as it descends into the pelvis, which will assist
with correctly performing the obstetric maneuvers required to relieve a shoulder dystocia,
should one occur.
Clinical Features
Retraction of the fetal head toward the perineum may be noted following the delivery of the
fetal head. The "turtle sign" is usually a significant clinical sign of impending shoulder
dystocia, but it is not necessarily diagnostic. Although there is no consensus on the clinical
criteria that are diagnostic of a shoulder dystocia, it is typically characterized by one of the
following parameters:
The delivering clinician is unable to deliver the fetal shoulders solely using gentle
downward traction.
Additional obstetric maneuvers become necessary to deliver the neonate successfully.
There is a documented head-to-body delivery interval of >1 minute
Pelvimetry is the measured assessment of the dimensions of the pelvis; it is most often used
to evaluate the risk of cephalopelvic disproportion in a pregnant individual. The 3 diameters
primarily used in pelvimetry to assess the pelvic inlet are the anterior-posterior (A-P), the
transverse, and the oblique diameters. Furthermore, the pelvic inlet's A-P diameter (ie,
conjugate) can be measured in 3 different ways. By measuring the distance from 3 separate
points along the pubic symphysis to the central point of the sacral promontory, various
aspects of the A-P diameter, also known as A-P conjugates, can be assessed. These
conjugates are the anatomical, diagonal, and obstetric conjugates.
The anatomic conjugate is the distance between the sacral promontory and the superior
margin of the pubic symphysis. Katanozaka et al. reported that parturients with an anatomic
conjugate of <12 cm were more likely to have a cesarean delivery due to labor dystocia than
those with larger conjugates. The diagonal conjugate is the distance between the
sacral promontory and the inferior margin of the pubic symphysis; it is the only conjugate
that can be directly assessed on a physical examination. This is done by palpating the sacral
promontory with the middle finger on a vaginal exam and then noting the distance from the
fingertip to the point the examining hand contacts the pubic arch, which is approximately
12.5 cm on average.
The obstetric (ie, true) conjugate is the distance between the sacral promontory and the
widest portion of the pubic symphysis, located between the superior and inferior margins of
the symphysis. The obstetric conjugate represents the smallest fixed distance through the
pelvic inlet. Although it cannot be measured directly on physical exam, it can be estimated by
measuring the diagonal conjugate and subtracting 1 to 2 cm; the average obstetric conjugate
measures approximately 10.5 cm. Some studies have demonstrated ultrasound imaging as an
effective, safe, and simple way to assess the obstetric conjugate antenatally to identify
patients who should be delivered by cesarean section due to a high risk for cephalopelvic
disproportion. Current guidelines, however, generally do not recommend making decisions
regarding the mode of delivery based on pelvimetry assessments, as a Cochrane review found
no evidence that pelvimetry imaging assessment improved outcomes.
Intrapartum Evaluation
Intrapartum conditions that may signal the possibility of impending shoulder dystocia include
a prolonged second stage of labor, failure of the fetal head to descend, and need for the
operative (ie, forceps or vacuum) vaginal delivery of the fetal head. However, while it is
essential to remain mindful of the risk factors for shoulder dystocia to prepare for delivery
properly, attempts to predict shoulder dystocia based on risk factors have shown poor
reliability and have a poor predictive value.
Therefore, shoulder dystocia remains a clinical diagnosis made after it occurs (eg, failure to
deliver the fetal shoulders solely with gentle downward traction, additional obstetric
maneuvers become necessary). Although professional societies have no agreed criteria to
diagnose shoulder dystocia, maneuvers to manage a shoulder dystocia should be initiated if a
shoulder dystocia is suspected due to characteristic signs (eg, turtle sign). Furthermore,
suspicion of shoulder dystocia should be announced to the rest of the obstetrical team. Also,
the delivery time of the fetal head should be noted so the team can track how much time has
elapsed before shoulder delivery occurs. After delivery, careful clinical assessment is
required for the infant (as well as the parturient) to look for potential traumatic injuries.
Treatment / Management
Shoulder dystocia is an obstetric emergency requiring preparation and training for proper
management by the delivering clinician and other obstetric team members. Not only does the
infant need to be delivered quickly, but healthcare professionals must also use a careful and
calm approach to mitigate the risk of injury to the parturient and the neonate.
Once a shoulder dystocia is identified, it is important for the delivering clinician to clearly
inform the other team members so they can immediately call for additional support (eg,
neonatal and anesthesia clinicians), assist with any maneuvers, and begin proper
documentation. The delivering clinician can then attempt specified obstetric maneuvers in a
sequential order to relieve the shoulder dystocia. Maneuvers are typically divided into first-
line, second-line, and heroic maneuvers. Fundal pressure should be avoided during shoulder
dystocia maneuvers. Not only does it not help with the delivery of the fetal shoulders, it may
worsen the shoulder impaction and increase the risk of uterine rupture. Furthermore, patients
should be instructed to stop pushing while the maneuvers are being performed.
First-Line Maneuvers
Second-Line Maneuvers
Delivery of the posterior arm: Some authors recommend this maneuver be used
before other second-line maneuvers if the McRoberts maneuver and suprapubic
pressure fail to result in delivery since some studies have suggested it may be most
effective in this group. To perform this maneuver, the obstetrical clinician slides a
hand along the posterior fetal shoulder and arm, grasps the forearm or wrist, and
sweeps the arm across the fetal chest to deliver the posterior arm. With the successful
delivery of the posterior arm, the relevant transverse diameter changes from the
bisacromial diameter (ie, shoulder-to-shoulder) to the acromial-axillary diameter (ie,
axilla-to-shoulder), which can be up to 3 cm shorter. This dislodges the anterior fetal
shoulder and allows for delivery. If the fetal forearm is not easily accessible (eg, when
the fetal arm is extended), the following additional maneuvers can be attempted to
gain access to the forearm or deliver the posterior fetal arm through alternative means:
o Fetal arm flexion: The delivering clinician slides a hand down the posterior
fetal arm until the antecubital fossa is palpated; pressure can then be applied to
the antecubital fossa, typically leading to flexion of the fetal arm and allowing
access to the forearm.
o Menticoglou maneuver: The delivering clinician places their middle fingers
under the posterior axilla and applies outward traction, which leads to delivery
of the posterior shoulder, followed by delivery of the posterior arm.
o Posterior axilla sling traction: A suction catheter or a soft urinary catheter
is positioned under the axilla of the posterior fetal arm and used as a sling.
Traction is applied to the sling to deliver the posterior shoulder, followed by
the arm. Alternatively, the sling can rotate the shoulders by applying lateral
traction toward the baby's back. At the same time, the other hand is placed on
the anterior shoulder, applying pressure toward the fetal chest.
Gaskin maneuver: The patient is placed onto her hands and knees (ie, an "all fours"
or "table-top" position); either gentle downward traction to the fetal shoulder closest
to the maternal sacrum or upward traction to the fetal shoulder against the maternal
symphysis pubis is then applied. If this is unsuccessful, other maneuvers (eg, delivery
of the posterior arm, rotational maneuvers) can also be attempted from this position.
This maneuver should only be used in patients without epidural analgesia.
Zavanelli maneuver: The fetal head is rotated to the occiput anterior position, flexed,
and pushed back up the vagina and into the uterus, effectively reversing the cardinal
movements of labor and relieving the compression on the umbilical cord. This fetus is
held in place until emergent cesarean delivery is performed.
Documentation by a member of the obstetrical team of delivery times and sequence of events
is vital not only to the delivering clinician but also to the patient and their future healthcare
practitioners. Furthermore, following the delivery, proper documentation assists clinicians in
reviewing what occurred during the delivery and counseling patients on subsequent
pregnancy risks. It also provides any future obstetrical clinicians involved in that patient's
care insight into the delivery events. Clinical information important to post-delivery
documentation includes pre-pregnancy maternal weight, total maternal weight gain, estimated
fetal weight, duration of active labor, duration of the second stage, and delivery time of the
fetal head and body.
Differential Diagnosis
When retraction of the fetal head against the perineum is noted (ie, the "turtle sign"),
differential diagnoses include a tight nuchal cord, fetal malposition, or normal delivery; these
can be excluded with a brief examination for a nuchal cord following delivery of the head and
when delivery of the anterior fetal shoulder is attempted.
Prognosis
Once a shoulder dystocia is relieved, the fetal and maternal prognosis depends on the severity
of complications that may develop. Maternal morbidities (eg, obstetric anal sphincter injury,
bladder laceration) may result in long-term issues, such as fecal incontinence. The most
common neonatal injuries, humerus and clavicle fractures and brachial plexus injuries, often
resolve without permanent disability. However, approximately 10% may result in permanent
neurologic injury. Simulation-based training has decreased the overall rate of shoulder
dystocia-related complications.
Complications
Maternal Complications
Shoulder dystocia can result in several maternal morbidities and are more frequent when
"heroic maneuvers" are performed. Maternal complications include:
Postpartum hemorrhage
Obstetric lacerations, including urethral, bladder, and 3rd- and 4th-degree perineal
lacerations with resulting urinary and fecal incontinence
Femoral and lateral femoral cutaneous neuropathies from prolonged use of the
McRoberts position secondary to nerve compression underneath the inguinal ligament
Symphiseal separation secondary to hyperflexion of maternal legs
Uterine rupture
Neonatal Complications
Fetal asphyxia, hypoxic encephalopathy, and death are fortunately much less common. They
most often occur after an average head-to-body delivery time of 10.75 minutes or using >5
maneuvers but are less common when the dystocia is relieved after the first maneuver. Head-
to-body delivery time is not predictive of the severity of neonatal injury, however, as neonatal
death has been seen to occur after intervals of <5 minutes.
Deterrence and Patient Education
Patient Counseling
Patients should be informed of risk factors for shoulder dystocia. Good glycemic control
during pregnancy and healthy weight gain should be emphasized, especially in patients with
gestational diabetes and obesity. For patients with a prior delivery complicated by shoulder
dystocia, it is crucial to convey to the mother that she has a 6- to 30-fold increased risk of
shoulder dystocia recurrence with any subsequent vaginal delivery.
ACOG recommends developing an obstetric rapid response team and protocols that can be
instituted based on clinical triggers. This team should include obstetric clinicians and nurses,
anesthesia personnel, and neonatal team members who will care for the infant immediately
after delivery.
This training should focus on correctly performing maneuvers, including heroic ones, and
practicing clear, standardized communication between team members. Regular practice in
managing emergencies through simulations can help ensure that all obstetric healthcare team
members are adequately trained in their respective roles when performing shoulder dystocia
maneuvers.
Participation in emergency drills can identify clinical errors frequently made during
emergencies, increase effective communication between healthcare team members, and
reinforce proper protocol. Several studies have shown that simulation training also reduces
maternal and neonatal morbidity.
Additionally, teams should always discuss the potential for shoulder dystocia in patients with
risk factors before delivery. Advanced consideration and planning will allow team members
to be mentally and physically prepared to act quickly as needed. The delivering clinician
should assess the fetal position during pushing and clearly communicate before delivery of
the fetal head which direction suprapubic pressure should be applied in case shoulder
dystocia becomes apparent.
Documentation by a member of the obstetrical team of delivery times and sequence of events
is vital not only to the delivering clinician but also to the patient and their future healthcare
practitioners. Furthermore, following the delivery, proper documentation assists clinicians in
reviewing what occurred during the delivery and counseling patients on subsequent
pregnancy risks. It also provides any future obstetrical clinicians involved in that patient's
care insight into the delivery events.
Children who suffer from obstetric brachial plexopathies have a generally good outcome with
conservative management and observation, though some may have permanent impairments.
In these cases, orthopedic surgeons, pediatricians, and therapists need to work closely in
concert with one another to optimize outcomes for the patient.
Uterine inversion
Uterine inversion is one of the most serious complications of childbirth. It refers to the
collapse of the fundus into the uterine cavity. Although it is rare, it carries a high risk of
mortality due to hemorrhage and shock.
Objectives:
Etiology
Excessive umbilical cord traction with a fundal attachment of the placenta and fundal
pressure in the setting of a relaxed uterus are the 2 most common proposed aetiologies
for uterine inversion. Other possible risk factors for uterine inversion include rapid labor,
invasive placentation, manual removal of placenta, short umbilical cord, use of uterine-
relaxing agents, uterine overdistension, fetal macrosomia, nulliparity, placenta previa,
connective tissue disorders (Marfan syndrome and Ehlers-Danlos syndrome), and history
of uterine inversion in the previous pregnancy. However, in most cases, no risk factors are
identified, thus making this condition unpredictable.
Incomplete: Fundus inverts but does not herniate through the level of the internal os
Complete: The internal lining of the fundus crosses through the cervical os with no
palpable fundus abdominally
Prolapsed: Entire uterus prolapsing through the cervix with the fundus passing out of
the introitus
Classification
Epidemiology
Pathophysiology
1. A portion of the uterine wall prolapses through the dilated cervix or indents forward
2. Relaxation of part of the uterine wall
3. Simultaneous downward traction on the fundus leading to the uterine inversion
Uterine inversion is a clinical diagnosis and should be suspected when the fundus is not
palpable abdominally. The sudden onset of brisk vaginal bleeding leads to hemodynamic
instability in the mother. Traditionally, the shock has been considered disproportionate to
blood loss, possibly mediated by parasympathetic stimulation caused by the stretching of
tissues. However, careful evaluation of the need for blood transfusion should be made
because blood loss is greatly underestimated. The other symptoms are mainly severe lower
abdominal pain with a strong bearing down sensation, though most women may not be able
to complain due to severe shock. It may occur before or after placental detachment.
Evaluation
The diagnosis is often made clinically with a bimanual examination, during which
the uterine fundus is palpated in the lower uterine segment or within the vagina. If a clinical
examination is equivocal, then an ultrasound can be used to confirm the diagnosis.
Treatment / Management
Differential Diagnosis
The conditions that cause a lump in the vagina and lead to postpartum collapse need to be
excluded. These include:
Prognosis
Acute cases can lead to hemorrhagic shock, but prompt management usually mitigates long-
term sequelae. It is unknown whether the condition affects future pregnancy prospects, but
case reports exist of uncomplicated pregnancies.
Complications
Complications associated with uterine inversion can be due to the condition (primary) or its
management (secondary). The condition's complications primarily revolve around
hemorrhage and its associated risks, including multi-organ damage, shock, Sheehan
syndrome, and hysterectomy). The condition can result in significant, persistent blood loss
and tissue necrosis without treatment. Complications accompanying treatment relate to
general anesthesia and blood transfusions.
Women who have experienced uterine inversion need to be counseled that they run the risk of
recurrence in subsequent pregnancies.
Enhancing Healthcare Team Outcomes
Uterine inversion is a true obstetric emergency that requires immediate treatment if the
patient's life is to be saved. An interprofessional team, including ICU nurses, best manages
the condition. The patient needs immediate resuscitation, a patent airway, blood transfusion,
and either manual or surgical management. The outcomes for most patients are guarded. (8)
Rupture of uterus
Objectives:
Etiology
Within pregnant women, there are two populations at risk for uterine rupture: those who
have a myometrial scar from previous surgery and those with an unscarred uterus. The cause
and risk factors for each group are different.
Great attention has been paid to the large increase in the cesarean section rate in the United
States over the past five decades. The cesarean section rate increased by 25% between 1970
and 2016.
TOLAC is one strategy to decrease the rate of cesarean births. The TOLAC has been shown
to reduce maternal morbidity and mortality during the index pregnancy as well as future
deliveries. While a successful vaginal birth resulting from TOLAC is associated with less
morbidity than a scheduled cesarean delivery, a failed TOLAC that ends in cesarean delivery
is associated with more morbidity than a scheduled cesarean delivery.
Thus, the safety of TOLAC is directly tied to the probability of successful vaginal birth.
Amongst the complications associated with TOLAC, uterine rupture is associated with the
largest increase in maternal and neonatal morbidity. Furthermore, it is estimated that the rate
of uterine rupture is approximately 15-30 times higher when women undergo a TOLAC
compared to a scheduled repeat cesarean delivery.
In women who attempt a TOLAC, those with a previous midline (inverted T or J shaped or
classical cesarean section) incision are at two to three times higher risk for uterine rupture
than those with a previous low segment transverse incision. Misoprostol administration is
associated with an increased rate of uterine rupture. The American College of Obstetricians
and Gynecologists now recommends against administering misoprostol to women undergoing
a TOLAC, with the exception only given to those women with a fetal demise. Interestingly, a
history of prior vaginal delivery significantly reduces the risk of subsequent uterine rupture.
While the incidence of unscarred uterine rupture is low, the rate is increasing. The rupture of
an unscarred uterus causes significantly more maternal and neonatal morbidity than the
rupture of a scarred uterus. Most ruptures involving unscarred uteri can be traced to one of
the following etiologies: (1) trauma, (2) a genetic disorder associated with uterine wall
weakness, (3) a prolonged induction or augmentation of labor, or (4) overstretching of
the uterine wall.
In the United States, most major abdominal trauma that occurs during pregnancy is due to
falls and motor vehicle accidents. Concern for uterine rupture is one reason fetal monitoring
is required after blunt abdominal trauma. Uterine rupture is also a concern during internal
podalic and external cephalic versions. For this reason, some obstetricians avoid neuraxial
anesthesia because they believe a uterine rupture may be missed if neuraxial anesthesia
conceals rupture-associated pain. Neuraxial anesthesia for external cephalic version has been
shown to improve patient comfort and improve the rate of successful version.
Epidemiology
Overall, it is estimated that one uterine rupture occurs for every 5,000 to 7,000 births. The
incidence of uterine rupture in both scarred and unscarred uteri is increasing worldwide
Uterine rupture is more common in women with prior cesarean delivery. The rate
of uterine rupture is highly dependent upon the number of cesarean deliveries a woman has
had and the type of uterine incision present. The rate of uterine rupture is approximately 1%
for women with one previous cesarean delivery versus 3.9% for those with greater than one
previous cesarean delivery.
The rate of uterine rupture with an unscarred uterus has been found to be approximately one
rupture per 10,000 to 25,000 deliveries. The incidence of uterine rupture in an unscarred
uterus is higher in developing countries. It is hypothesized that this rate is higher because
techniques to manage obstructed labor, such as instrument-assisted and cesarean delivery, are
less readily available.
Pathophysiology
Uterine rupture refers to the complete division of all three layers of the uterus: the
endometrium (inner epithelial layer), myometrium (smooth muscle layer), and perimetrium
(serosal outer surface). Generally speaking, the term uterine rupture implies that a gravid
uterus is involved—though ruptures have been reported in nonpregnant uteri.
A uterine rupture can allow a part of the fetus, amniotic fluid, or the umbilical cord to enter
the peritoneal cavity or broad ligament. A uterine rupture can cause abdominal pain, vaginal
bleeding, a change in the contraction pattern, or a nonreassuring fetal heart rate tracing.
The presentation of a woman with a uterine rupture is highly dependent upon whether they
have a labor epidural, a scared or unscarred uterus, and the location of the rupture.
For women with a suspected uterine rupture, the initial assessment is for hemodynamic
stability. Blood pressure and heart rate should be obtained to assess for hypotension and
tachycardia. Common symptoms of hypotension include lightheadedness, dizziness, nausea,
vomiting, and anxiety. Most of the bleeding associated with a uterine rupture is
intraabdominal and cannot be detected by the patient. When vaginal bleeding occurs, it is
helpful to differentiate between light spotting and significant blood-soaked linen.
Patients with a uterine rupture may describe acute onset abdominal pain that begins with a
“ripping” sensation. Subsequent contracts are often quite painful. Chest pain may occur if
blood enters the peritoneum. Blood in the peritoneum can irritate the diaphragm and cause
referred to shoulder or chest pain similar to ischemic cardiac pain. A labor epidural may mask
the pain associated with a uterine rupture and lead to delayed diagnosis.
The fetal heart rate provides insight into both the health of the fetus and the health of the
woman—the fetal heart rate is one of the most sensitive indicators of maternal end-organ
perfusion. Reduced blood flow to the fetus can present as fetal bradycardia, reduced
variability, or late decelerations. Fetal bradycardia is the most common abnormality
associated with uterine rupture. No fetal heart rate tracing is pathognomonic
for uterine rupture. The absence of fetal heart sounds is obviously an ominous sign and
requires an ultrasound to confirm absent cardiac activity.
Palpating the abdomen to localize the area of most pain and guarding can be helpful in
women with a suspected uterine rupture. A uterine rupture should cause midline pain. Most
women with a uterine rupture will have a tender abdomen, even when receiving labor
epidural analgesia. Palpation of the abdomen can also provide insight into whether the
contraction pattern or uterine shape has changed. Uterine contraction amplitude may
decrease, and contractions may stop altogether in women who experience a uterine rupture.
An internal examination can identify products of conception, fresh blood, or clots in the
vaginal canal. In a uterine rupture, the vaginal canal is usually not full of blood—unless the
tear extends into the vagina or cervix. Speculum examination may help diagnose non-
pregnancy related bleeding such as a laceration or abnormal cervical growth. A vaginal exam
can also identify loss of fetal station (movement of the fetal presenting part towards the
abdominal cavity), which can occur with a uterine rupture if part of the fetus enters the
peritoneum.
Evaluation
Due to the potential for serious maternal and neonatal morbidity, uterine rupture must be
excluded in all cases of vaginal bleeding during pregnancy. The classic symptoms described
for uterine rupture include acute onset abdominal pain, vaginal bleeding, a non-reassuring
fetal heart rate tracing, and a change in the contraction pattern on
tocodynamometry. Unfortunately, these symptoms are often not present. Radiographic and
laboratory tests can be helpful in diagnosing a minor uterine rupture. Imaging is not
appropriate when there is a significant rupture because of the emergent need for delivery and
hemorrhage control.
The most important initial laboratory test is hemoglobin or hematocrit. If significant bleeding
has occurred, coagulation tests (prothrombin time, activated partial thromboplastin time,
fibrinogen, thromboelastogram) should be considered. If significant bleeding has not yet
occurred, baseline hemoglobin or hematocrit can be used to monitor for ongoing blood loss.
In a stable patient with a possible minor rupture, an ultrasound can be helpful to rule out other
etiologies for vaginal bleeding, such as placenta previa, placental abruption, or spontaneous
abortion. The following findings on abdominal ultrasound support the diagnosis
of uterine rupture: an abnormality in the uterine wall, a hematoma next to a hysterotomy
scar, free fluid in the peritoneum, anhydramnios, or fetal parts outside the uterus.
Ultimately, the diagnosis of uterine rupture is often confirmed when hemoperitoneum and
fetal parts are identified during laparotomy.
Treatment / Management
Differential Diagnosis
The differential diagnosis for second and third trimester vaginal bleeding in the setting of
acute abdominal pain includes spontaneous abortion, bloody show associated with normal
labor, placenta previa, placental abruption, and uterine rupture.
Bloody show refers to mucus mixed with blood that is discharged prior to the onset of labor.
Bloody show may precede labor by as much as three days. The blood loss associated with
bloody show is small, and patients remain hemodynamically stable.
Placenta previa refers to the placenta attaching to the uterus over the cervical opening. A
placenta previa is one of the more common causes of second and third trimester
bleeding. The classic description of placenta previa is painless vaginal bleeding
unaccompanied by uterine contractions. However, some patients with placenta previa may
have crampy contraction pain. Most placenta previas can be diagnosed by ultrasound. It is
important not to perform a digital examination in patients with 2nd or 3rd trimester vaginal
bleeding until a placenta previa has been ruled out. Digital examination of the cervix when a
placenta previa is present may result in life-threatening maternal hemorrhage.
A placental abruption refers to the placenta separating from the uterus before delivery. Most
placental abruptions occur around 25 weeks. In an abruption, maternal blood vessels tear
away from the decidua basalis, the uterine endometrium at the site of placentation, and push
the placenta and uterus apart.
Patients may report vaginal bleeding, acute onset abdominal pain, and continuous crampy
contractions due to blood irritation. Similar to a uterine rupture, placental abruption may
cause non-reassuring fetal heart rate changes. However, placental abruption is more likely to
be associated with tetanic uterine activity than a uterine rupture.
Significant blood can accumulate behind a placental abruption and remain undetectable by
ultrasound examination. Ultrasonography has poor sensitivity for diagnosing a placental
abruption. If blood loss is significant, an abruption can be life-threatening for both the woman
and the neonate.
Uterine rupture occurs rarely but must be ruled out in all cases of 2 and 3 trimester vaginal
bleeding. The biggest risk factor for a uterine rupture is TOLAC. Most uterine ruptures
occur during labor. A uterine rupture should be considered in all women undergoing a
TOLAC who present with any of the following: hypotension, a sudden change in contraction
pattern, fetal bradycardia, sudden abdominal pain, hematuria, loss of fetal station, or vaginal
bleeding.
Prognosis
With quick surgical intervention and resuscitation, most women survive a uterine rupture.
The maternal mortality rate associated with the rupture of an unscarred uterus is higher (10%)
than the mortality rate associated with the rupture of a scarred uterus (0.1%).The neonatal
mortality rate after uterine rupture is 6% to 25%.
The risk of recurrent rupture after the uterine repair is not well described. This is because the
incidence of rupture is low, and many women with a significant uterine rupture require a
hysterectomy. In a few small case series conducted outside the United States, the incidence of
repeat rupture was 33% to 100%. There is low-level evidence that the repeat rupture rate may
be higher when the initial rupture occurs in the uterine fundus. Due to the maternal and fetal
risk of repeat rupture, most obstetricians recommend repeat cesarean delivery between 36 and
37 weeks—before labor is allowed to begin.
Complications
The incidence of serious fetal and maternal morbidity depends upon the location and
magnitude of the rupture as well as the speed of surgical intervention. Lateral ruptures are
associated with worse outcomes than midline ruptures—perhaps because of increased
vascularity of the lateral uterine wall. A longer time to surgical intervention is associated
with more maternal blood loss, a higher risk of coagulopathy, and longer fetal exposure to
hypoxia.
Rupture of unscarred uteri is associated with more blood loss, a higher incidence of
hysterectomy, and a higher rate of composite maternal morbidity (death, hysterectomy, blood
transfusion, or urologic injury) than rupture of scarred uteri. The incidence of composite fetal
neurologic injury (intraventricular hemorrhage, seizure, death, or brain ischemia) is also
higher for ruptures involving an unscarred uteri, compared to scarred uteri. The rate of fetal
mortality is 10% for unscarred uteri and 2% for scarred uteri.
Consultations
Given the potential for maternal and fetal morbidity associated with a uterine rupture,
prevention strategies are prudent. Women at higher risk for uterine rupture (e.g., multiparity,
multiple gestations, advanced maternal age, connective tissue disorders) should receive
oxytocin judiciously. Likewise, procedures that may cause a uterine rupture, such as the
internal podalic and external cephalic version, should be performed gently and with careful
consideration for the type of anesthesia. Lastly, significant pressure applied to the uterus
during the second stage of labor should be avoided. This practice has not been shown to
shorten the second stage of labor, and it increases the risk for uterine rupture.
Women with risk factors for uterine rupture should be educated on the early signs and
symptoms of rupture. It is recommended that women at high risk for uterine rupture reside
near their delivery hospital.
Due to the potential for uterine rupture and significant fetal and maternal morbidity the
availability of providers in obstetrics, anesthesia, pediatrics, as well as operating room
personnel should be considered when making a plan for a TOLAC [Level 5 evidence]. Due to
the risk of uterine rupture, TOLAC should be performed in locations where emergent
cesarean delivery is offered [Level 5 Evidence]. (9)
Amniotic fluid embolism
Amniotic fluid embolism (AFE) is a rare but serious condition with high mortality and
morbidity rates and is the second leading cause of peripartum maternal death. It occurs when
amniotic fluid enters the maternal bloodstream.
Objectives:
Introduction
The initial description of AFE dates back to 1941 when Steiner and Luschbaugh noted fetal
cells in the maternal pulmonary circulation of women who died during labor. Data from the
National Amniotic Fluid Embolism Registry indicates that the condition shares similarities
with anaphylaxis rather than a typical embolism.
Notably, fetal tissue or amniotic fluid components are not consistently detected in women
displaying signs and symptoms of AFE. Traditionally, AFE diagnosis occurred postmortem,
relying on the presence of fetal squamous cells in the maternal pulmonary artery
blood. However, as fetal squamous cells are also found in the circulation of laboring women
who do not develop AFE, the diagnosis is exclusionary and based on clinical presentation
after ruling out other causes of hemodynamic instability.
Etiology
AFE remains unpredictable, with an elusive origin. Various factors contribute to its
development, encompassing maternal age (especially older than 35 to 40 years), grand
multiparity, male fetuses, early gestational age, cervical ripening, polyhydramnios, multiple
gestation, gestational diabetes, operative delivery, manual placental extraction, regional
disparities (western U.S.), Asian and Black races, asthma, illicit substance use, and trauma.
Induction of labor and conditions such as cerebrovascular disorders and cardiac disease
heightens the risk of AFE, with strong associations observed in placenta previa, eclampsia,
uterine rupture, fetal growth restriction, fetal death, placental abruption, maternal renal
disease, peripartum cardiomyopathy, and postpartum hemorrhage.
There is some conflicting evidence on the risk factors for AFE. Many earlier studies
concluded that cesarean delivery, particularly with a classical uterine incision, raised AFE
risk. This concept has since been reversed, with cesarean section of any type found to be
unrelated. Similarly, amniotomy was once thought to increase the risk of AFE but is now
believed to be uncoupled. One population-based case-cohort study looked at 149 cases of
AFE, 80 of which were fatal. They reported that a spontaneous vaginal delivery had 12 times
the risk of AFE than cesarean delivery, and instrumental vaginal delivery was almost 3 times
the risk of cesarean delivery. They concluded that cesarean section is a protective factor for a
fatal AFE. Amnioinfusion does correlate with a 3-fold increase in AFE risk, potentially due
to increased uterine distension. Notably, 66% of AFE patients reported prior allergies,
aligning with the condition's secondary name, "anaphylactoid syndrome of pregnancy,"
exceeding the general population's atopy rate. Additionally, 8% of AFE-affected pregnancies
stem from in vitro fertilization, surpassing the baseline IVF rate.
Placenta accreta spectrum (PAS) disorder emerges as the anomaly most strongly linked to
AFE, carrying a 10-fold increased risk. The severity of PAS correlates with a higher AFE
incidence. Introducing amniotic fluid and fetal components into maternal circulation triggers
intense pulmonary vasoconstriction and bronchoconstriction. These effects result not only
from physical obstruction but primarily from the release of inflammatory cytokines reacting
to foreign material. These mediators activate coagulation and fibrinolytic pathways,
culminating in a DIC syndrome.
Epidemiology
The estimated incidence of AFE ranges from 1.9 to 6.1 per 100,000 births, though the exact
prevalence remains uncertain due to inaccurate diagnosis and underreporting of nonfatal
cases. Notably, AFE emerged as the primary cause of death during parturition in Germany in
2011 and accounts for 24.3% of maternal deaths in Japan. In Australia, AFE is recognized as
the leading direct cause of maternal mortality, affecting between 1 in 8000 to 1 in 80,000
deliveries. The estimated incidence in the UK is 2 per 100,000 births, while in the United
States, AFE occurs at approximately 7.7 per 100,000 births.
A significant majority of AFE cases, around 70%, manifest during labor, with approximately
19% occurring during cesarean sections and 11% following vaginal deliveries. It is
noteworthy that AFE can occur up to 48 hours after delivery. Rare instances of AFE have
been reported after pregnancy termination, amniocentesis, injection of hypertonic saline into
the uterus for abortion induction, and in the first or second trimester of pregnancy.
Pathophysiology
Accompanying the entry of amniotic and fetal substances are tissue factors with procoagulant
properties. Activation of histamine, endothelin, and leukotrienes leads to physiologic changes
that result in cardiovascular collapse. Potential portals of entry include the placental
attachment, cervical veins, or uterine surgical incisions. Once within the pulmonary arterial
tree, this triggers a pathological maternal anaphylactoid immune response, releasing
inflammatory mediators.
The initial phase involves intense and transient pulmonary vasoconstriction, possibly coupled
with bronchoconstriction. This results in acute pulmonary arterial obstruction, dilation of the
right ventricle and right atrium, and significant tricuspid regurgitation. Subsequently, hypoxia
and right heart failure ensue. There is a less common type of AFE reported, which presents
with only the hemorrhage and DIC component without maternal hemodynamic instability.
Histopathology
Despite the presence of amniotic fluid substances in the lungs, their microscopic
identification can be challenging due to their minute size.
Histological examinations may not always capture these tiny particles, potentially
leading to under recognition.
Alveolar Hemorrhage
These clinical pearls shed light on the intricate pathological aspects of AFE, emphasizing the
importance of considering macroscopic and microscopic findings in diagnosing and
understanding this complex obstetric emergency.
The medical history or current health details of a patient experiencing an AFE may reveal
factors such as advanced maternal age, multiple pregnancies, placenta-related issues (accreta,
abruption, previa), preeclampsia, gestational diabetes, polyhydramnios, amniocentesis, use of
amnioinfusion, amniotomy, cervical lacerations, or any surgery on the gravid uterus. In the
classic scenario, women in the later stages of labor suddenly develop acute shortness of
breath accompanied by hypotension. Preceding other symptoms, there may be signs of
agitation, anxiety, altered mental status, or a sense of impending doom. Seizures may ensue,
leading to cardiac arrest, followed by massive hemorrhage associated with DIC, ultimately
resulting in death—often within an hour of onset. Statistics indicate that 53% of females with
AFE present at or just before delivery, while the remainder present, on average, 19 minutes
after delivery.
AFE commonly manifests with cardiac arrest, but other presentations include respiratory
collapse and DIC. Many patients lose consciousness, and some may exhibit seizure-like
activity (10% to 50%), likely due to brain anoxia. The physical examination typically reveals
a patient in cardiovascular collapse, marked by severe hypoxemia, hypotension, and cyanosis.
The classic triad of AFE consists of hypoxia, hypotension, and coagulopathy, with a normal
body temperature. Funduscopic examination may detect minute bubbles in retinal arteries.
Tachypnea may be present, often accompanied by the characteristic holosystolic high-pitched
murmur of tricuspid regurgitation. This murmur is loudest at the lower left sternal border,
radiating to the right sternal edge. Hemorrhage can range from massive to minimal, and
uterine atony (83%) exacerbates bleeding. Initial bleeding typically occurs from the vagina
but may also be observed in surgical incisions. Full-blown DIC is observed in approximately
83% of patients. Premonitory symptoms, such as shortness of breath or agitation, may
precede cardiovascular collapse.
Evaluation
The diagnosis of AFE relies on exclusionary criteria after the occurrence of a clinical
scenario that aligns with its characteristics. It is fundamentally a clinical diagnosis, as no
reliable, definitive test for AFE exists. The suspicion of AFE arises when sudden dyspnea,
dysphoria, hypotension, cardiovascular collapse, and coagulopathy manifest following
actions during the peripartum period, such as active labor, rupture of membranes, vaginal
delivery, or cesarean section. AFE has also been observed during or after elective pregnancy
terminations, whether induced or surgical. Initial evaluation typically occurs during
aggressive cardiopulmonary resuscitation, focusing on the 2 main system failures:
hemodynamic and hematologic.
Immediate blood collection is essential for an urgent type and crossmatch, complete blood
count, comprehensive metabolic panel, and a full coagulation panel, encompassing platelets,
prothrombin time, partial thromboplastin time, bleeding time, fibrinogen, d-dimer, and fibrin
degradation products (FDPs). The International Society on Thrombosis and Hemostasis
(ISTH) provides a formal scoring system for determining DIC presence in pregnancy
based on platelet count, international neutralization ratio (INR), and fibrinogen level.
Scores >3 indicate the presence of DIC in pregnancy.
Establishing precise criteria for diagnosing AFE has been challenging due to the absence of a
single definitive test. Various international standards have been introduced to define AFE,
with the American Society for Maternal-Fetal Medicine (SMFM) establishing objective
criteria following a consensus symposium with the Amniotic Fluid Embolism Foundation in
2016. The criteria stipulate the presence of the following conditions:
Treatment / Management
Due to the rarity of AFE, many obstetric clinicians lack experience in managing such cases.
To mitigate panic and confusion and enhance coordination among healthcare providers, it has
been proposed that a checklist could be a beneficial cognitive aid in the initial and immediate
management of a patient with an AFE. The overall treatment approach for a patient with an
AFE is supportive, with initial management aligning with the "ABC" principles, prioritizing
the support of the airway, breathing, and circulation.
During chest compressions, defibrillator pads should be applied without interruption, and a
non-synchronized shock should be administered if the cardiac rhythm is shockable.
Cardiopulmonary resuscitation should continue for 2 minutes, followed by a pause to check
for a pulse and analyze the rhythm. It is recommended to change providers, ensuring that no
one person gives chest compressions for more than 2 minutes. If indicated, a second shock
may be administered, and the process should be repeated.
For the mother, comprehensive care involves securing the airway, effective ventilation,
appropriate fluid management, and judicious use of vasopressors. Intra-arterial lines facilitate
real-time pressure measurement and frequent arterial blood gas sampling. A central venous
pressure line aids in assessing right-sided preload. Recognizing the adverse impact of copious
fluid administration on clotting factors and bleeding, the decision to transition to vasopressors
should be contemplated earlier as compared to later when resuscitating a patient with
significant bleeding from other causes.
Pulmonary hypertension and right heart failure commonly accompany AFE, making
inotropes, pulmonary vasodilators, and after-load reducing agents paramount to treatment.
Vasopressor support should be initiated with norepinephrine if needed. Dobutamine and
milrinone, as inotropes, provide pulmonary vasculature dilation and a decrease in right
ventricular afterload. Epoprostenol, whether inhaled or intravenous, for pulmonary
vasodilation may be used instead of inhaled nitric oxide or sildenafil with similar outcomes
for right ventricular failure. Ideal management involves maintaining a mean arterial pressure
(MAP) >65 mmHg, a cardiac index >2 L per meter squared, an adequate urine output of 40
mL/hr to 50 mL/hr, and a PaO2/FiO2 ratio >250.
Extracorporeal membrane oxygenation (ECMO) life support has proven successful for
refractory cardiogenic shock secondary to AFE when severe right ventricular
dysfunction does not respond to medical management. ECMO provides respiratory and
hemodynamic support through the femoral vasculature until the right ventricle's function
improves. Any patient persisting in cardiopulmonary collapse should have femoral arterial
and venous 4 Fr sheaths placed in anticipation of ECMO. Transferring to tertiary facilities
capable of ECMO may require early decision-making and awareness of local capabilities.
Anticoagulation-free ECMO should be considered if ongoing bleeding or DIC is present.
Following fetal delivery, managing hemorrhage, uterine atony, and the resulting
coagulopathy (DIC) is the next step. Empirical administration of packed red blood cells
(pRBCs), fresh frozen plasma (FFP), and platelets in a 1:1:1 ratio has been traditional.
However, cryoprecipitate is preferred over FFP to reduce volume overload, given its
concentrated clotting factors, including factor VIII, von Willebrand factor, and fibrinogen.
Tranexamic acid may be administered for fibrinolysis. Blood products are used for fluid
resuscitation to mitigate the risk of volume overload.
Standard laboratory turnaround times for clotting parameters may be too slow for actively
bleeding patients. Viscoelastic hemostatic assay (VHA)-guided algorithms have
demonstrated reduced transfusion requirements, offering improved outcomes. Whole blood
viscoelastic hemostatic assays, such as thromboelastography and rotational
thromboelastometry, performed at the bedside, provide minute-to-minute evaluation of
clinically relevant information, aiding in the rapid assessment and treatment of major
obstetric hemorrhage, as seen in AFE. These measurements include fibrinogen levels, platelet
count and function, and evaluation of the entire extrinsic clotting pathway, guiding
appropriate administration of cryoprecipitate, fibrinogen, prothrombin complex concentrates,
platelets, FFP, and pRBCs.
While investigational, anecdotal reports in the literature cite the use of several other
medications, including rivaroxaban, a factor Xa inhibitor, C1 esterase inhibitor concentrate,
ketorolac, ondansetron, and aminocaproic acid.
Obstetrical management must prioritize the rapid evacuation of the fetus, usually by cesarean
section. The Society for Maternal-Fetal Medicine recommends this for all fetuses over
23 weeks gestational age. Evacuation of the uterus may not improve the clinical situation
with a previable fetus or even with a gestational age of less than 20 weeks. Ongoing
resuscitation of the mother in the delivery room, with an anesthesiologist or critical care
provider overseeing cardiovascular resuscitation, must continue during the infant's extraction.
Shifting the gravid uterus to the left is recommended, relieving aortocaval compression.
Differential Diagnosis
AFE is prone to misdiagnosis, prompting ongoing efforts to clarify its etiology, risk factors,
and pathogenesis. Vigilance must be taken for potentially reversible causes, including
hypovolemia, hypoxemia, and hypothermia. Consideration of underlying reversible diagnoses
such as myocardial infarction or tamponade, acidosis, hyperkalemia, and tension
pneumothorax is warranted. The differential diagnosis for a pregnant patient experiencing
complete cardiovascular collapse during or around the time of delivery, followed by
significant hemorrhage, should encompass the following:
AFE exhibits some similarities to pulmonary embolus but lacks an ongoing coagulopathy
seen in PE. Postpartum cardiomyopathy would likely manifest significant ST-T wave
changes on electrocardiography, accompanied by predominant symptoms of left-sided
congestive heart failure. Bedside echocardiography (TEE or TTE) can aid in distinguishing
AFE with its classic right ventricular dilatation, overload pattern, and septal bowing into the
left ventricle.
Septic shock typically presents with the classic systemic inflammatory response syndrome
(SIRS) picture and is unlikely to lead to sudden cardiovascular collapse. Myocardial
infarction, unless antecedent to the cardiac arrest, would display typical ST-T wave changes
and elevated serial cardiac enzymes, observable through bedside echocardiography. Venous
air embolism usually presents with wheezing, gasping, and chest pain before cardiovascular
collapse. Eclampsia may be suggested by hypertension, edema, proteinuria, headaches, or
seizures preceding the collapse. Anaphylaxis should exhibit premonitory symptoms like
wheezing, dyspnea, rash, urticaria, and a period of hypotension before cardiovascular
decompensation. Cephalad distribution of spinal anesthetic would present with an elevated
sensory level, weakness of the upper extremities, difficulty in speaking, dysphagia, and
bradycardia.
Prognosis
Tragically, within the first hour following an AFE, an estimated 50% of patients succumb,
and two-thirds face mortality within 5 hours. The peak period of death has been noted to be 1
to 12 hours after the AFE occurs. A California-based study indicated that 26.4% of affected
pregnant patients died, while 66% developed DIC. Maternal survival remains uncommon, but
prompt recognition and resuscitation improve prognoses. The United Kingdom AFE registry
reported a 37% mortality rate, with 7% of survivors experiencing neurological impairment.
Survivors of AFE often grapple with substantial neurological, pulmonary, and cardiovascular
deficits, affecting two-thirds of these recently pregnant patients. Recurrence risks are
uncertain, but instances of successful subsequent pregnancies have been
documented. Elective cesarean delivery recommendations for future pregnancies to mitigate
labor-related risks are contentious.
Infant mortality rates hover around 30%, accompanied by elevated risks of hypoxic-ischemic
encephalopathy, cerebral palsy, and cognitive disabilities among survivors. The grim
statistics extend to stillbirth and neonatal death, reaching rates as high as 10% to
40%. Patients who survive pregnancies complicated by AFE commonly grapple with
depression and post-traumatic stress disorder (PTSD).
While initial rates of neurologically intact survival were reported at 15%, recent data suggests
an improvement, with estimates nearing 46%. Advances in diagnosis, medical management,
and a deeper understanding of AFE's pathophysiology contribute to enhanced survival rates.
Early recognition has not only benefited maternal outcomes but has also resulted in improved
neonatal mortality and morbidity rates.
Complications
Survivors of AFE may contend with a spectrum of significant complications, including the
following:
Renal failure
Cardiac failure
Prolonged respiratory failure leading to adult respiratory distress
Myocardial infarction
Arrhythmias
Cardiomyopathy
Congestive heart failure
Left ventricular systolic dysfunction
Prolonged coagulopathy
Respiratory failure (extended)
Prolonged bronchospasm
Liver failure
Cardiogenic pulmonary edema
Seizures
Anoxic encephalopathy
Various cognitive or neurologic impairments
Infants delivered emergently during maternal AFE are at heightened risk for sustaining
hypoxic-ischemic encephalopathy (HIE). This often results in a significantly cognitively
impaired child, potentially manifesting chronic epilepsy, motor impairment, and
developmental delay.
Future studies are crucial to identifying individuals at the highest risk, as long-term mental
and physical health consequences are prevalent in these patients. It is noteworthy that only
around 60% of women affected by AFE manage to return to their previous state of well-
being. Further research can contribute to a better understanding of risk factors and improve
preventive strategies.
The abrupt onset of cardiovascular collapse and profound coagulopathy in mothers, coupled
with the imperative for neonatal resuscitation, renders the management of AFE highly
intricate and demanding for any interdisciplinary team. Successful outcomes for both the
mother and infant hinge on seamless coordination among various healthcare professionals,
including obstetricians, maternal-fetal specialists, anesthesiologists, labor and delivery
nurses, neonatologists, intensivists, hematologists, perfusionists, respiratory therapists, and
neonatal intensive care unit nurses.
Shock is defined as a state of circulatory inadequacy with poor tissue perfusion resulting in
generalized cellular hypoxia. Circulatory inadequacy is due to a disparity between the
circulating blood volume and the capacity of the circulatory bed.
The net effect of this disparity is inadequate exchange of oxygen and carbon dioxide between
the intra and extravascular compartments. The stagnation of carbon dioxide and other
metabolites in the tissue leads to metabolic acidosis and cellular death.
The series of changes observed in shock and their clinical manifestations are therefore,
dependent on two sets of changes (a) Circulatory inadequacy at the ‘filtration’ level
(microvascular compartment), (b) Cellular damage and ultimately death.
Micro vascular circulation consists of circulation of blood through a tuft of capillaries with a
feeding arteriole and a draining venule at either end of the capillary bed. The f low of blood
within the capillary bed is controlled by 2 sphincters—one at the arteriolar end and the other
at the venular end. They are known as pre and postcapil lary sphincters. In addition to the tuft
of capillaries, there is a direct communication between the arteriole and the venule and this
communicating trunk bypasses the cap illary bed. This is known as metarteriole shunt or ‘thor
oughfare channel’. When the sphincters are closed, the metarteriole shunt operates to divert
blood for supply to the vital organs, like brain, heart and kidney.
Pathophysiology of shock
Pathophysiological changes in obstetric shock are pre dominantly associated with (a) general
changes due to hypovolemia, and (b) specific changes due to liberation of endotoxin.
Hypotension stimulates release of neuroendocrine mediators like adrenocorticotropic
hormone (ACTH), growth hormone (GH), b endorphin, cortisol and glucagon.
Cytokines such as interleukins (ILS) and tumor necrosis factor (TNF) interact by autocrine
and paracrine mechanisms to cause cellular or organ dysfunction. In the presence of hypoxia,
sepsis and acidosis, lysosomal enzymes which are cytotoxic, are released. They can cause
myocardial depression and coronary vasoconstriction. Prostacyclin is a vasodilator and
inhibits platelet aggregation.
Thromboxane A2 causes pulmonary vasoconstriction and platelet aggregation. Leukotrienes
cause vasoconstriction, platelet activation and increased vascular permeability. Endothelium-
derived relaxing factor (EDRF) which is identified as nitric oxide (NO) is found to produce
sustained vasodilatation and hypotension.
HEMORRHAGIC SHOCK
Basic management of hemorrhagic shock is to stop the bleeding and replace the volume which has
been lost. Prompt diagnosis and immediate resuscitation is essential failing which multiple organ
failure develops.
Restore circulating volume (Infusion and transfusion): Blood should be transfused, especially in
hemorrhagic shock as soon as it is available. Crystalloids: Normal saline has to be infused initially for
immediate volume replacement. But they are rapidly lost from circulation. Colloids: Polygelatin
solutions (Hemaccel, Gelofusion) are isoosmotic with plasma. They do not interfere with the
coagulation system. Large volumes can be administered. They promote osmotic diuresis. Dextrans:
They are polymolecular polysaccharides.
They interfere with crossmatching and they are avoided. Human albumin solutions (4.5%)—not
generally used for volume replacement. Maintenance of cardiac efficiency: When a large vol ume of
fluid or blood is to be administered, the cardiac competence or efficiency should be ascertained, other
wise there is a risk of overloading the circulation and cardiac failure. 6 liters of crystalloids may be
needed for the loss of 1 liter of plasma volume. One or two large bore (14 or 16-gauge) cannula are
inserted for volume replacement. Packed red blood cells (specific blood component), combined with
normal saline, are used for hemorrhagic shock. Hemodynamic monitoring is aimed at maintaining.
systolic BP >90 and MAP >60 mm Hg, CVP 12–15 cm H2O and pulmonary capillary wedge pressure
14–18 mm Hg.
Administration of oxygen to avoid metabolic acidosis: In the initial phase, administration of oxygen
by nasal cannula at a rate of 6–8 liters per minute is enough but in the later phases, ventilation by
endotracheal intuba tion may be necessary. Oxygen delivery should be continued to maintain O2
saturation >92%, PaO2 80–100 mm Hg, PaCO2 30–35 mm Hg and pH >7.35.
Endotracheal intubation and mechanical ventilation may be needed for patients with septic shock.
Indications of mechani cal ventilation are: severe tachypnea (RR >40/min), altered mental status,
severe hypoxemia, despite O2 supplementation. Pharmacological agents: Use of vasopressor drugs
should be kept to a minimum, since peripheral vaso constriction is already present. The role of
vasoactive drugs, inotropes and corticosteroids in shock has been discussed in detail in connection
with management of endotoxic shock. Control of hemorrhage: Specific surgical and medical treatment
for the control of hemorrhage should start along with the general management of shock. The specific
management of each variety of obstetric hemorrhage has been outlined in the related chapters.
Monitoring: Clinical parameters like skin temperature, and visible peripheral veins can be helpful to
assess the degree of tissue perfusion. Urine output (>30 mL/hr) is a useful guide. Arterial blood
pressure is a poor indicator to assess tissue perfusion. Invasive monitoring may not be needed in a
straight forward case. In a critically ill patient, however, measurement of central venous pressure
(CVP), to assess the adequacy of patient’s circulating volume and the contractile state of the
myocardium, is essential. Pulse oximeter and blood gas analysis are useful to assess tissue perfusion.
Measurement of left atrial pressure (pulmonary artery occlusion pressure) by ‘SwanGanz’ catheters
could be done in selected cases.
ENDOTOXIC SHOCK Investigations to organize in a patient with septic shock: CBC, hematocrit,
coagulation profile, (platelet count, serum fibrinogen, FDPs, PT, APTT), liver and renal function
tests, chest radiograph, USG, CT or MRI may be needed (for localizing pelvic pathology or pelvic
abscess, pneumonia or ARDs), and also ECG monitoring.
The principles of management are: (a) to correct the hemodynamic instability due to sepsis
(endotoxin), (b) to appropriate supportive care, and (c) to remove the source of sepsis.
Women with obstetric complications need access to quality maternal health services that
can detect and manage life-threatening obstetric complications. These women need 24/7 pers
onalized care by skilled providers, essentially led by obstetricians or Emergency Obstetric Ca
re (EmOC) trained providers. For a small proportion of women who have progressed to a
clinical condition where there is multi‐organ involvement/failure, the care has to be provided
in an intensive care unit setting led by intensivists/super‐specialists.
In India, most of the public health facilities do not have a separate special care unit for
high-risk pregnancies and postpartum mothers with complications. Such women are being
managed in the labor room, without a dedicated team(s) of competent providers and
appropriately equipped facilities.
To further bring down the MMR, facility of skill based services in dedicated critical care set
up, with state‐of‐the‐art equipment and technology and a team of appropriately trained
professionals are the need of the hour.
Any pregnancy can develop life threatening complications at any time with or without any
warning.
When things go wrong in obstetrics, they go wrong fast – “they fall off a cliff”.
Medical conditions might present a risk to the pregnancy, and pregnancy may also modify
the disease state.
Drug therapy may be affected by altered pharmacokinetics during pregnancy, and may
have an impact on the fetus.
Process of Shifting of a Patient from Ward/ Triage Room to HDU or ICU/ Obstetric ICU
The key steps to be taken are:
[Link] the family/companion of pregnant woman of the decision, and take consent.
[Link] patients should be escorted by doctor/staff with all existing treatment including
continuation of patent IV line.
7. Oxygen and supine hypotension prevention (by performing lateral tilt to 15‐
20 degree),if required.
Research article
2. Nekkanti AC, Hazra D, George RM, Yalamanchili S, Kumari P, Samuel ST, et al.
Pregnancy-related emergencies: Profile and outcome. J Fam Med Prim Care. 2020 Sep
30;9(9):4618–22.
3. Ngene N. Obstetric Emergencies. Case Rep Women Health. 2020 Sep 15;
4. ABC of labour care: Obstetric emergencies - PMC [Internet]. [cited 2024 Sep 8]. Available
from: [Link]
5. Wong L, Kwan AHW, Lau SL, Sin WTA, Leung TY. Umbilical cord prolapse: revisiting its
definition and management. Am J Obstet Gynecol. 2021 Oct 1;225(4):357–66.
7. #37: Diagnosis and management of vasa previa - American Journal of Obstetrics &
Gynecology [Internet]. [cited 2024 Sep 8]. Available from:
[Link]
8. Thakur M, Thakur A. Uterine Inversion. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2024 [cited 2024 Sep 8]. Available from:
[Link]
9. Togioka BM, Tonismae T. Uterine Rupture. In: StatPearls [Internet] [Internet]. StatPearls
Publishing; 2023 [cited 2024 Sep 8]. Available from:
[Link]
10. Haftel A, Carlson K, Chowdhury YS. Amniotic Fluid Embolism. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 8]. Available
from: [Link]